Helsinn is a leader in cancer supportive care, and Vice Chairman and CEO Riccardo Braglia enthusiastically discusses the Group’s entrance into the field of oncology therapeutics and the launch of the new Helsinn Investment Fund.
Helsinn Advanced Synthesis in Biasca is a very advanced site capable of synthesizing high containment oncology compounds, some very specialized applications, and as such we have worked with many of the leading American, Swiss and Japanese companies as a manufacturing partner
